Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.49.5
PrivacidadTérminosCookiesAviso Legal
● Connected
SOLV US Equity
Solventum Corp
87.29USD▲ 1.02%
Healthcare
Medical Instruments & Supplies
96)Comparar97)Tesis →
Market Cap
$14.9B
Shares Outstanding
170M
EV/EBITDA
7.1×
— Annual —FY2025
Revenue
$8.3B
Gross Margin
53.5%
Operating Margin
26.2%
Net Margin
18.7%
FCF Margin
-0.1%
ROE
30.8%
ROCE
19.6%
Net Debt/EBITDA
1.6×
Current Ratio
1.23
D/E Ratio
1
FCF / Share
-0.06
Book Value / Share
29.66
SOLV US Equity
87.29USD▲ 1.02%
Tesis →

Solventum Corp (SOLV): análisis fundamental y valoración

Solventum Corp cotiza a 87.29 USD y tiene una capitalización bursátil de $14.9B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNYSEPaísUnited StatesEmpleados20,584Beta0.69Web↗ www.solventum.com

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems. The Medsurg segment off…

Múltiplos de Valoración
P/E (Annual)
9.6×
P/E (TTM)
—
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
7.1×
EV/Revenue
2.3×
P/Sales
1.8×
P/Book
2.9×
Rentabilidad (Último Anual)
Gross Margin
53.5%
Operating Margin
26.2%
Net Margin
18.7%
FCF Margin
-0.1%
ROE
30.8%
ROCE
19.6%
ROA
10.9%
Effective Tax Rate
9.2%
Métricas TTM
Revenue TTM
—
Gross Profit TTM
—
Operating Income TTM
—
Net Income TTM
—
FCF TTM
—
EPS TTM
—
Quarters Used
—
TTM Period
—
Solidez del Balance
Net Debt
$4.2B
Net Debt / EBITDA
1.6×
Debt / Equity
1
Current Ratio
1.23
Interest Coverage
—
Working Capital
$723M
Book Value / Share
29.66
Net Debt / Share
24.42
Crecimiento (YoY)
Revenue YoY
+0.9%
Net Income YoY
+224.8%
FCF YoY
-101.2%
EPS Diluted YoY
+221.7%
Retorno al Accionista
Dividend Yield
—
Payout Ratio
—
FCF / Share
-0.06
CapEx % Revenue
4.5%
Rev / Employee
404,440
Próximos Eventos
Historial EPS
Periodo2026-112026-082026-052026-02
Real—$2.55$1.48$1.57
Estimado$1.35$1.91$1.35$1.50
Sorpresa—+33.5%+9.6%+4.7%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaSOLVMediana SectorΔ
Gross Margin53.5%57.0%-3.6%
Operating Margin26.2%-38.6%+64.8%
Net Margin18.7%-33.6%+52.3%
FCF Margin-0.1%-13.9%+13.7%
ROE30.8%-40.4%+71.2%
ROA10.9%-32.0%+42.9%
Current Ratio1.232.84-1.61
Debt / Equity1.000.28+0.72
Scoring Fundamental
Piotroski F-Score
6/ 9Moderado
✓F1ROA positivo (rentabilidad activos)
✓F2Flujo caja operativo positivo
✓F3ROA mejora vs año anterior
✗F4Calidad de beneficios (OCF > ROA)
✓F5Apalancamiento baja
✓F6Liquidez mejora (current ratio)
✗F7Sin dilución accionarial
✗F8Margen bruto mejora
✓F9Rotación activos mejora
Altman Z-ScoreZona Gris
2.29
x1_working_capital0.051
x2_retained_earnings0.126
x3_ebit0.153
x4_market_equity1.607
x5_sales0.582
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
5/ 8Moderada
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✗Rev↑Revenue CAGR 3 años > 5%
✓ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✓Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos